Advocacy Actions
Submit Comments/Recommendations to CFDA on the Draft Guidance for Medical Software Evaluation
Submit Comments/Recommendations to CFDA on the Draft Guidance for Medical Software Evaluation
Read moreMeeting with China Association of Medical Equipment (CAME)
COCIR, MITA and CAME exchanged opinions about delelopmtent of the Medical Imaging Industry as well as "Buy China" Initatives of the NHFPC.
Read moreMeeting with Medical Imaging & Technology Alliance (MITA)
COCIR and MITA agreed to have regular meetings (monthly) to 1) exchange industry updates 2) discuss joint efforts on concrete industry issues if it’s appropriate 3) align lobby points with the Chinese authorities, eg. for JCCT from US side, and EU-China Regulators Dialogue.
Read moreMeeting with Japanese Chamber of Commerce Life Science Group on Position Paper
Exchange of opinions on the position papers medical devices / life science of the two chambers
Read moreSubmit Comments/Recommendations to CFDA Different Departments jointly with CAMDI
Submit Comments/Recommendations to CFDA Different Departments jointly with CAMDI
Read moreSeminar on the Medical Software (MSW) Review Guidance to be published by CFDA
Seminar in preparation of drafting the CFDA's guidelines for evaluation of Medical Software
Read moreCDMD GA Subgroup Meeting with the Department of Health of Shandong Province
Officials from the Provincial Department of Health and Members of the Chamber's CDMD desk exchanged information and opinions on the definition of Medical Service Items as well as the upcoming provincial tender for high-value consumable medical devices.
Read moreCDMD GA Subgroup Meeting with the Pricing Bureau of Shandong Province
The pricing bureau and delegates from the Medical Device Industry exchanged information about the trends in determining medical service items and their pricing
Read moreMeeting with the EU Delegation, Counsellors of Sante, Trade and Growth
Confirm regular meetings (e.g. market access meeting, eHealth round table):
Comments to CFDA's "Classification Rules for Medical Devices"
The Chamber submitted consolidated Comments to the "Principles of Classification of Medical Products" (Revised Draft) of the CFDA. http://www.sfda.gov.cn/WS01/CL0779/110264.html
In a previous Call for Comments within the HCE Working Group, four member companies had forwarded their comments to the chamber.